The FDA record for K260586 lists Tactile Medical of Minneapolis, Minnesota, as applicant for the Nimbl™ Pneumatic Compression System, received February 20, 2026, and decided October 27, 2026, as substantially equivalent under a Traditional clearance with a summary. The device is classified as a compressible limb sleeve, Class II, regulation 870.5800, product code JOW, in the Cardiovascular advisory committee. Tactile Medical’s own product pages and user guides describe Nimbl as a pneumatic compression device with a controller and garments for upper and lower extremity lymphedema. [1][2][3]
The documented device and its components
Tactile Medical’s clinician page describes Nimbl as having an eight-compression-chamber design, multiple pressure modes and inflation sequencing, with a controller weighing less than two pounds. The patient page describes a 60-minute daily treatment that applies a squeezing action intended to move lymphatic fluid away from the affected area. The user guide identifies Model PD08-N1 and lists customer care contacts for the system. [2][4][3]
The FDA record classifies the device as a compressible limb sleeve and names the device as the Nimbl™ Pneumatic Compression System, with the applicant at 3701 Wayzata Blvd., Suite 300, Minneapolis, MN 55416. That address appears in the filing and is not treated here as a verified headquarters. [1]
Filing scope and dated examples
The linked collection contains one 510(k) record, K260586, with a single SESE decision; the record sample likewise contains one entry with one SESE decision. These counts describe the filings retrieved as of November 20, 2026, and are not measures of total company sales, total portfolio or safety performance. [1]
The K260586 record shows a Traditional clearance, no third-party review, a summary statement and a Cardiovascular review committee. The user guide carries a 2025 copyright and revision 703935-001 Rev F dated 7/2025, while an earlier bilateral guide is revision C. [1][3][5]
Applicant identity and corporate documentation
Tactile Systems Technology, Inc. filed a Form 10-Q for the quarterly period ended June 30, 2026, signed August 10, 2026 by Elaine M. Birkemeyer. The FDA applicant name on K260586 is Tactile Medical; the record does not establish a parent-subsidiary relationship between the two names, so that link remains unverified in these sources. [6][1]
Tactile Medical’s website presents lymphedema and respiratory solutions and lists Flexitouch, ComfortEase, Nimbl, Kylee, Entre, Healing Right at Home and Lifting Care. Everywhere. as its trademarks or registered trademarks. The same trademark notice appears on the Nimbl patient and clinician pages. [7][2][4]
What the record does not establish
The sources do not document pricing, payer coverage, sales figures, clinical outcome rates, patient-selection criteria or commercial availability beyond the FDA decision and the manufacturer’s published materials. The customer care hours differ between the revision F guide and the earlier revision C guide, and the current schedule is not resolved here. [3][5][1]



